ResMed Acquires Germany's Mementor and Its Insomnia Digital Health Solution Somnio.

MANews-(C)2009-2022

US-based medical equipment company ResMed (NYSE: RMD) (ASX: RMD) has acquired Germany-based insomnia Digital Health Application company Mementor, the company said.

With this acquisition, ResMed strengthens its overall sleep portfolio in Germany with a digital solution for insomnia.

Founded in 2014 and based in Leipzig, Germany, mementor developed and owns the digital insomnia therapy solution somnio, which is Germany's first and only permanently approved Digital Health Application in the field of sleep medicine and thus eligible for reimbursement in Germany.

It's also compliant with the European Union's data protection requirements under the General Data Protection Regulation.

ResMed said Somnio closes a gap in the care of insomnia patients and complements its efforts to increase both awareness of this disease and access to effective home treatments.

Through the acquisition, mementor can leverage ResMed Germany's broader network to increase adoption of its approved digital therapy alternative for insomnia; somnio is...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT